DalsnaFinance

Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results

Markets GlobeNewswire By GlobeNewswire 16 Jun 2026 13:10 1 min read
Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results

– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets

– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets

Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.com

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.